// STATE LEGISLATION TRACKER

Rhode Island SB 2889 — AN ACT RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Rhode Island
Bill: SB 2889
Session: 2026
Filed: 2026-03-04
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

This bill appears to relate to Rhode Island's controlled substances law, not peptide prescribing or compounding. Based only on the title, subjects, and lack of recorded actions, there is no clear direct impact on compounded peptides, off-label peptide prescribing, telehealth peptide care, NP/naturopath scope, or FDA 503A/503B compounding.

Key Points

No clear peptide-specific language is available from the provided record
Controlled-substance changes usually do not affect most peptides directly
No clear change to telehealth peptide prescribing is shown
No clear change to NP or naturopathic peptide scope is shown

What to Watch For

Note Watch for bill text or amendments that mention compounding, pharmacies, prescribing, or monitoring programs.

Concern If later text expands controlled-substance rules, clinicians may face more paperwork for unrelated controlled meds.

Note No recorded actions means the bill's practical effect cannot be assessed beyond the title.

Where the Bill Stands

The provided source says no actions are recorded, so the bill's current procedural status is unclear.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws